{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:50:11Z","timestamp":1791039011770,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.brainres.2006.01.116","type":"journal-article","created":{"date-parts":[[2006,3,4]],"date-time":"2006-03-04T12:24:05Z","timestamp":1141475045000},"page":"196-204","source":"Crossref","is-referenced-by-count":43,"title":["Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain"],"prefix":"10.1016","volume":"1082","author":[{"given":"Y.","family":"Oida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kitaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2006.01.116_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2165\/00003088-197803020-00002","article-title":"Clinical pharmacokinetics of rifampicin","volume":"3","author":"Acocella","year":"1978","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.brainres.2006.01.116_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2006.01.116_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","article-title":"Neuroprotective effect of riluzole in MPTP-treated mice","volume":"918","author":"Araki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2006.01.116_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0076-6879(94)33026-3","article-title":"Oxidative chemistry of peroxynitrite","volume":"233","author":"Beckman","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.brainres.2006.01.116_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chroma.2003.12.041","article-title":"High-performance liquid-chromatographic determination of rifampicin in plasma and tissues","volume":"1031","author":"Calleja","year":"2004","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.brainres.2006.01.116_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nm0198-092","article-title":"The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor","volume":"4","author":"Callija","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2006.01.116_bib7","doi-asserted-by":"crossref","first-page":"13256","DOI":"10.1074\/jbc.M314124200","article-title":"Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases","volume":"279","author":"Choi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2006.01.116_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2006.01.116_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study","volume":"9","author":"Dexter","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2006.01.116_bib11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1471-4159.1994.63030793.x","article-title":"Altered brain metabolism of iron as a cause of neurodegenerative diseases?","volume":"63","author":"Gerlach","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2006.01.116_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1021944113833","article-title":"Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs","volume":"23","author":"Gollapudi","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.brainres.2006.01.116_bib14","first-page":"906","article-title":"Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative)","volume":"255","author":"Hara","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2006.01.116_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(91)90367-Y","article-title":"Amelioration of brain damage after focal ischemia in the rat by a novel inhibitor of lipid peroxidation","volume":"197","author":"Hara","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.01.116_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)90700-E","article-title":"Effects of baicalein and alpha-tocopherol on lipid peroxidation, free radical scavenging activity and 12-O-tetradecanoylphorbol acetate-induced ear edema","volume":"221","author":"Hara","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.01.116_bib17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","article-title":"1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles","volume":"170","author":"Hasegawa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2006.01.116_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.brainres.2006.01.116_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2006.01.116_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.57.4.732","article-title":"Rifampicin is not an activator of glucocorticoid receptor","volume":"57","author":"Herr","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2006.01.116_bib22","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2006.01.116_bib23","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.01.116_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1248\/jhs.50.443","article-title":"Strategy in a living body to protect against oxidative stress-induced damage","volume":"50","author":"Kikugawa","year":"2004","journal-title":"J. Health Sci."},{"key":"10.1016\/j.brainres.2006.01.116_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-004-0867-6","article-title":"Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro","volume":"108","author":"Kilic","year":"2004","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.brainres.2006.01.116_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2006.01.116_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.41.2_Part_1.202","article-title":"Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease","volume":"41","author":"Kostic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.01.116_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002826-198612000-00001","article-title":"MPTP: current concepts and controversies","volume":"9","author":"Langston","year":"1986","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2006.01.116_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2006.01.116_bib32","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0021-9258(18)99728-0","article-title":"The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol","volume":"241","author":"Mellors","year":"1966","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2006.01.116_bib33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/31.5.731","article-title":"Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats","volume":"31","author":"Mindermann","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.brainres.2006.01.116_bib34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0140-6736(92)92870-L","article-title":"Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients","volume":"340","author":"Namba","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2006.01.116_bib35","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2006.01.116_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2006.01.116_bib37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/WNL.47.4.1037","article-title":"Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose\u2013response study and correlations with plasma levels","volume":"47","author":"Pappert","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.01.116_bib39","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.brainres.2006.01.116_bib40","first-page":"L699","article-title":"The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide","volume":"268","author":"Pryor","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2006.01.116_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-291X(86)80483-1","article-title":"Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+","volume":"134","author":"Ramsay","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2006.01.116_bib43","first-page":"51","article-title":"On\u2013off effects in Parkinson's disease: a controlled investigation of ascorbic acid therapy","volume":"37","author":"Reilly","year":"1983","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.brainres.2006.01.116_bib44","first-page":"197","article-title":"A marker of oxyradical-mediated DNA damage (8-hydroxy-2-deoxyguanosine) is increased in nigro-striatum of Parkinson's brain","volume":"3","author":"Sanchez-Ramos","year":"1994","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.brainres.2006.01.116_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.brainres.2006.01.116_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease","volume":"328","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2006.01.116_bib47","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","article-title":"Inhibition of amyloid \u03b2 protein aggregation and neurotoxicity by rifampicin","volume":"271","author":"Tomiyama","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2006.01.116_bib48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.brainres.2006.01.116_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-977X(03)00065-8","article-title":"Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study","volume":"14","author":"Watanabe","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2006.01.116_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10715769709097783","article-title":"Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics","volume":"26","author":"Whiteman","year":"1997","journal-title":"Free Radical Res."},{"key":"10.1016\/j.brainres.2006.01.116_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2003.10.012","article-title":"Rifampicin attenuates brain damage in focal ischemia","volume":"996","author":"Yulug","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2006.01.116_bib53","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","article-title":"Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons","volume":"154","author":"Zhang","year":"1999","journal-title":"Am. J. Pathol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T14:49:42Z","timestamp":1627138182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899306003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0006899306003131"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2006.01.116","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}